Home › Funds › SPHERA FUNDS MANAGEMENT LTD. › SNDX

SPHERA FUNDS MANAGEMENT LTD. position in SNDX

SYNDAX PHARMACEUTICALS INC · Health Care

SPHERA FUNDS MANAGEMENT LTD. reported holding 1,014,606 shares of SNDX (SYNDAX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$22.2M, representing 3.10% of its reported portfolio and ranking #5 among its reported holdings. SPHERA FUNDS MANAGEMENT LTD. has disclosed SNDX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.01M sh
Reported value held$22.18M
Portfolio Weight3.10%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SPHERA FUNDS MANAGEMENT LTD.'s SNDX position evolved

SPHERA FUNDS MANAGEMENT LTD. first disclosed a stake in SNDX in Q3 2023 at 773,061 shares (US$11.2M). The position peaked in Q2 2026 at 1,014,606 shares, worth US$22.2M. Across 12 filings, SPHERA FUNDS MANAGEMENT LTD. increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,014,606 shares valued at US$22.2M — an increase of 290,043 shares quarter over quarter.. Notable position changes include a 75% trim in Q3 2025 (shares rose 37% over the following quarter), a 97% increase in Q4 2025 (shares rose 11% over the following quarter), a 40% increase in Q2 2026 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 773.06K $11.22M New
Q4 2023 772.96K $16.70M Hold
Q1 2024 812.96K $19.35M Add
Q2 2024 822.05K $16.88M Add
Q3 2024 1.03M $19.92M Add
Q4 2024 1.38M $18.26M Add
Q1 2025 1.66M $20.44M Add
Q2 2025 1.57M $14.72M Reduce
Q3 2025 387.72K $5.97M Reduce
Q4 2025 762.56K $16.02M Add
Q1 2026 724.56K $16.93M Reduce
Q2 2026 1.01M $22.18M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SNDX and 13F data

SNDX (SYNDAX PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in SNDX — the largest reported positions include Kynam Capital Management, LP (US$176.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$82.6M), Eversept Partners, LP (US$61.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SNDX

All SNDX fund holders →

FAQ

How long has SPHERA FUNDS MANAGEMENT LTD. held SNDX?

SPHERA FUNDS MANAGEMENT LTD. has disclosed SNDX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is SPHERA FUNDS MANAGEMENT LTD.'s current position in SNDX?

As of Q2 2026, SPHERA FUNDS MANAGEMENT LTD. holds 1.01M shares of SNDX (SYNDAX PHARMACEUTICALS INC), valued at $22.18M, representing 3.10% of its reported portfolio and ranking #5.

Has SPHERA FUNDS MANAGEMENT LTD. been buying or selling SNDX?

In the latest 13F filing (Q2 2026), SPHERA FUNDS MANAGEMENT LTD. increased its position in SNDX. The position peaked in Q2 2026 at 1.01M shares.

Which other funds hold SNDX?

Other major institutional holders of SNDX include Kynam Capital Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P., Eversept Partners, LP, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.